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This review describes a series of experiments designed to investigate the ability of isolated chondrocytes 
seeded onto scaffolds to produce cartilaginous matrix and heal lesions in meniscal cartilage. Devitalized 
cartilaginous matrices were seeded with isolated articular chondrocytes, stacked and wrapped in fibrin 
glue, and implanted subcutaneously in nude mice. Samples were harvested at different time points, 
ranging from one week to eight months and analyzed grossly, histologically, histomorphometrically and 
biomechanically. The efficacy of the seeded cells to generate an active tissue and bond cartilage matrices 
together was demonstrated. Subsequent studies were performed to apply this methodology to the repair 
of meniscus tissue. Articular chondrocytes were seeded onto meniscal slices and inserted ex vivo into 
bucket-handle lesions of ovine menisci. Samples were wrapped in fibrin glue and implanted in nude mice. 
The capacity of seeded chondrocytes to repair a lesion in the meniscal tissue was demonstrated after 
fourteen weeks of implantation and encouraged us to move to the application of this cell-based repair 
method to a pre-clinical large animal model. Autologous chondrocytes were seeded onto devitalized 
allogeneic meniscal slices and sutured inside a meniscal lesion. After nine weeks from implantation, 
gross, histological and histomorphometrical results showed bonding of the margins of the lesions in 
the experimental group. In conclusion, this series of experiments demonstrated the ability of seeded 
chondrocytes to produce active cartilaginous matrix with healing capability. The successful application 
of these findings to the repair of meniscal tissue is a potential new tool for meniscus repair.
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Large populations of patients suffer from pain, 
stiffness, and loss of structure and function related 
to cartilage defects resulting from burns, tumors, 
trauma, arthritis, or other metabolic causes. Injured 
cartilaginous tissues have limited innate capabilities 
for healing and self-regeneration, and the reparative 
tissue that generally forms does not resemble the 
native cartilage in biochemical composition or 
biomechanical properties. Consequently, injury to 
cartilages in articulating joints, the cranium, and 
other cartilaginous tissues often results in scar 
formation leading to permanent loss of structure and 
function (1).
In joints, for example, cartilages of the meniscus 
and the articular surface are partially or completely 
isolated from the vascular environment. This lack 
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of vascularity, combined with the extreme forces 
to which the articulating cartilage is subjected, 
probably impedes the normal wound repair processes 
observed in vascularized tissues like skin. Current 
surgical techniques for cartilage repair rely heavily 
on either autogenous composite tissue grafts or on 
the placement of artificial prosthetic implants. More 
recently, techniques have been introduced to re-
implant autologous, cultured chondrocytes delivered 
to the lesion as cell suspension (2-3) or carried by 
biologically derived tissue membranes (4-8). Each of 
these techniques has often demonstrated imperfect 
clinical results, but also has some serious drawbacks 
that limit clinical utility. Harvesting autologous 
tissue to obtain cells can result in unwanted 
donor site morbidity and may cause additional 
complications over the long term. Furthermore, the 
repair tissue has not been fully evaluated in restoring 
normal biochemical composition and biomechanical 
properties. On the other hand, prosthetic metallic or 
plastic implants undergo migration, extrusion, and 
unknown long-term side affects (9-10).
During the last decade, many investigators have 
reported studies involving isolated chondrocytes 
seeded in natural or synthetic scaffolds, including 
collagen gel (11-14), fibrin glue (15-16), polyglycolic 
acid (17), polyethylene oxide gel (18), alginate 
gel (19), carbon fiber pads (20), and devitalized 
xenogeneic matrix (21). Using these methods, the 
transplantation of previously isolated and cultured 
chondrocytes into articular cartilage defects were 
performed in several animal models which include 
chick (22), rabbit (14,23), dog (24) and horse (13,25). 
In spite of all these efforts, however, the repair of 
cartilaginous tissues still remains a challenge.
Developing a minimally invasive method for the 
in vivo generation of new cartilage to permanently 
repair cartilage defects in these patient populations 
has been the primary goal of our laboratory. To 
achieve the desired result, however, one must 
consider both the properties of the native tissue at 
the site of injury and the properties of the scaffold 
being used to deliver the cells to generate cartilage 
repair tissue. Most importantly, however, the 
engineered cartilage must integrate into the defect 
and heal to the surrounding cartilage at the site of 
implantation. Generating engineered cartilage tissue, 
the integration of this neo-cartilage with native 
cartilage, and the ability of the cells to bond or heal 
cartilaginous matrices are the primary goals of the 
following studies.
MATERIALS AND METHODS
Experimental development of cartilaginous tissue 
bonding
The first fundamental step in this series of experiments 
was to ascertain whether isolated chondrocytes could 
adhere to cartilage matrix and have the ability to promote 
integration of separate fragments of cartilage (26). As 
depicted in the diagram in Fig. 1, slices of articular 
cartilage were harvested from lambs and devitalized 
by five freeze-thaw cycles. Devitalized cartilage matrix 
was employed to eliminate any possible contribution of 
chondrocytes residing in the slices, and, therefore, only 
test the new cartilage generated by cells seeded onto the 
dead matrices. Chondrocytes were isolated from cartilage 
of animals of the same species by collagenase digestion. 
The slices were then either co-cultured for three weeks 
in the presence (cellular density of 0.2 million/ml) or 
absence of chondrocytes in suspension culture in Ham 
F12 medium with 10% fetal bovine serum, 50 mg/ml 
ascorbate, 292 mg/l glutamine and antibiotics in order to 
allow chondrocytes to adhere to the matrices. Composites 
of three such slices were assembled, wrapped in fibrin 
glue, and implanted into nude mice for 7, 14, 21, 28, and 
42 days. Bonding of the experimental matrices with viable 
dividing chondrocytes was achieved at 28 and 42 days as 
assessed by direct examination and histology. No bonding 
occurred in the control composites without chondrocytes 
(Fig. 2). In particular, bonding of the composites were 
examined grossly with a pair of jewelers forceps for the 
existence of tissue planes between the slices of cartilage 
matrix and the ability to separate the tissue planes 
by passive opening the forceps. Cell mitotic activity 
was tested by [3H]thymidine uptake at time 0 (before 
implantation), 14, 28 and 42 days following implantation. 
Histological evaluation of samples before implantation 
showed presence of few layers of live chondrocytes on 
the surface of devitalized cartilage matrix in experimental 
samples, whereas no vital cells were found in control 
samples (Fig. 3). Moreover, examination of samples 
after implantation documented chondrocytes forming 
new cartilage matrix in the contact planes between the 
slices of experimental composites. This new cartilage 
layer increased in thickness from day 7 to day 42 with 
obliteration of the space between the matrices observed 
by day 21. The fibrin glue layer shrank progressively and 
disappeared by day 21 (Fig. 4 and 5). At later observation 
time points, erosion of the devitalized matrix could be 
sporadically noted with ingrowth of new cartilage (Fig. 6). 
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Analysis by fluorescence microscopy of samples treated 
with fluorescent dye solutions (live/dead kit: calcein and 
ethidium homodimer) confirmed that this invading tissue 
was composed of live cells penetrating into the devitalized 
cartilage matrix (data not shown). The [3H]thymidine 
study showed a statistically significant decrease in 
incorporation into the experimental composites from day 
0 to day 28 followed by a slight increase at day 42 (Fig. 
7). From these results, we concluded that proliferating 
chondrocytes could achieve confluence at the interface and 
integration of the devitalized cartilage matrices. Although 
we were able to follow the adhesion process of the newly 
formed tissue throughout the experimental times, we were 
not able to measure the strength of these bonds. 
The main goal of the following experiment was 
designed in order to investigate the ability of chondrocytes 
to adhere to and remodel devitalized cartilage matrix, and 
most importantly, to quantify the biomechanical properties 
of the tissue bond by tensile testing (27). Standardized 
articular hyaline cartilage discs (5mm X 1mm) were 
harvested from the articular joints of lambs and 
devitalized by freeze-thaw cycles. Articular chondrocytes 
were enzymatically isolated from cartilage pieces from 
animals of the same species. The devitalized cartilage 
discs were incubated in the presence (experimental) or 
absence (control) of chondrocytes in suspension culture 
for three weeks. After in vitro culture, pairs of cartilage 
discs were held in apposition in fibrin glue and implanted 
subcutaneously in nude mice for up to six weeks. Two 
experimental samples (with cells) and one control (without 
cells) were implanted in each mouse. Groups of 5 mice 
were sacrificed at 1, 2, 3, 4, and 6 weeks after implantation. 
Mechanical testing was performed on the samples 
after which the tissues were formalin fixed, processed, 
sectioned, and stained with Safranin-O. Some specimens 
in each group were fixed immediately upon collection for 
pre-test histological evaluation. The mechanical integrity 
of newly formed tissue was evaluated by tensile testing 
on a Dynastat mechanical spectrometer. Chondrocyte-
matrix constructs were attached to plexiglass rods using 
cyanoacrylate glue and the rods were mounted in the 
Dynastat. Tensile displacements were applied at a rate of 
10 μm/s to failure and the resultant loads were recorded. 
Sample displacements and loads were normalized to 
strain and stress by sample geometry and tensile strength, 
fracture strain, fracture energy, and tensile modulus were 
calculated from the resultant stress-strain curves (Fig. 
8). The histological examination showed new cartilage 
matrix formed by chondrocytes adhered to devitalized 
matrix, leading to complete fusion of the two matrix 
discs by week 3. This was consistent with the previous 
study (Fig. 4). Starting at week 3, the newly synthesized 
cartilage formed buds of penetration in devitalized matrix, 
which became more frequent with time. Histological 
analysis of biomechanically tested samples showed that 
failure occurred at the interface between new matrix 
and devitalized cartilage (Fig. 9A). Moreover, post-test 
histological evaluation showed that the presence of these 
buds of penetration stabilized the interface between new 
tissue and matrix, with failure occurring on opposite 
side of these formations in 80% of the cases (Fig. 9B). 
Mechanical testing indicated that tensile strength (Fig. 
10A), fracture strain (Fig. 10B), fracture energy (Fig. 
10C) and tensile modulus (Fig. 10D) increased with time 
for the experimental group while control group showed no 
increase. By six weeks, this resulted in 10-fold increase 
in tensile strength (p<.01), 50-fold increase in fracture 
energy (p<.01), 10-fold increase in fracture strain (p<.01), 
and a 3-fold increase in tensile modulus (p<.05). 
The results from this study confirmed that 
transplanted chondrocytes had the ability to adhere 
to devitalized cartilage and synthesize new matrix. 
Further, these chondrocytes had the capacity to repair 
and remodel the cartilage matrix in a way that increases 
the biomechanical properties of the tissue construct. The 
level of biomechanical function reported in this model 
was encouraging, given that all reported properties 
increased with time. This motivated us to perform longer-
term studies, which could yield specimens with superior 
appearance and mechanical properties. Therefore, the 
experiment was repeated (28) for an extended study, but 
the cell and matrix source was changed from lamb to 
juvenile pig. Again, the chondrocyte-matrix constructs 
were assembled with fibrin glue, implanted in dorsal 
subcutaneous pockets in nude mice (Fig. 11), and assessed 
at 1, 2, 4, and 8 months after implantation. Histological 
analysis from this study also confirmed that chondrocytes 
grown on devitalized cartilage discs produced new 
matrix that was able to bond and integrate cartilage 
discs. Biomechanical testing (Fig. 12) demonstrated a 
time dependent increase in tensile strength, failure strain, 
failure energy, and tensile modulus to values 5-30% 
of normal articular cartilage by eight months in vivo. 
Importantly, the values recorded at four months were not 
statistically different from those collected at the latest 
time point, indicating that the limits of the biomechanical 
property values were reached after four months from 
implantation.
Simultaneously, we decided to further analyze the 
morphological appearance of the living cells at the 
interface between the newly formed tissue and the 
devitalized cartilaginous scaffold matrices (29). In fact, we 
believed that the chondrocytes in this area were somehow 
more active in the remodeling process of the cartilage 
matrix scaffolds and, most importantly, these cells played 
an important role in the bonding capacities of the newly 
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formed cartilaginous tissue. As in the previous protocols, 
articular cartilage was harvested from young sheep and 
seeded onto pieces of devitalized sheep cartilage. The 
seeded pieces were stacked in pairs and wrapped in fibrin 
glue, and then implanted subcutaneously in the dorsum of 
athymic mice. Samples were harvested after 6 weeks and 
examined by transmission electron microscopy (TEM) 
or by light microscopy. After harvesting and processing 
of the samples, TEM revealed that the cells distant from 
the interface with scaffold tissue were more rounded in 
shape with large nuclei that appeared similar to normal 
chondrocytes (Fig. 13A). On the other hand, the cells 
in direct apposition to the devitalized cartilage were 
elongated, with an enlarged cytoplasm, and a ruffled 
border (Fig. 13B). Quantitative morphometry of histology 
specimens revealed that cell area, relative amount of 
cytoplasm (with respect to the nuclear area), cell aspect 
ratio (between major axis and minor axis, indicating 
elongation of the cell), and relative nuclear displacement 
(in the periphery or in the center of the cell) were all 
higher in cells near the interface with the scaffold tissue, 
and decreased with distance from the interface. These 
findings of cell morphology were all considered indices 
of active remodeling of the scaffold at the cell–scaffold 
interface.
Experimental development of meniscal tissue healing
The capacity of seeded chondrocytes to bond 
cartilaginous matrices inspired us to seek another important 
application for this model—the healing of lesions in the 
knee meniscus. Since menisci play a crucial role in knee 
function (30-34), significant effort has been attempted to 
salvage these structures following injury. This structure is 
not entirely vascularized and a blood supply is found only 
peripherally in the outer third (35). As a result, reparative 
process cannot occur in lesions involving the avascular 
inner portion of the meniscus (36). Based on the results 
from our previous work, it seemed reasonable to initiate 
studies on the application of this bonding phenomenon to 
meniscal tissue. The purpose of the following study (37) 
was to utilize chondrocyte-seeded cartilaginous scaffolds 
for repairing bucket-handle type of lesions in devitalized 
meniscal tissue in an in vivo nude mouse model. 
As depicted in the diagram of Fig. 14, meniscus 
specimens were harvested from the inner third of the 
menisci of lambs. Menisci were treated with five freeze-
thaw cycles to devitalize the matrix.  A four-millimeter 
bucket-handle lesion was created with a knife about two 
millimeters from the free margin of the avascular zone. 
Meniscal slices (4mm X 2mm X 0.5mm) were sectioned 
from the same tissue. Articular chondrocytes were 
isolated from cartilage from animals of the same species 
by overnight digestion in collagenase. The devitalized 
meniscal slices were incubated in the presence (cellular 
density of 0.2 million/ml) or absence (control) of 
chondrocytes in suspension culture in Ham F12 media 
with 10% FBS, 50 mg/ml ascorbate, and antibiotics for 
21 days in order to allow chondrocytes to adhere to the 
slices. After in vitro culture, the meniscus slices with 
seeded chondrocytes (experimental group 1) and without 
chondrocytes (control group 2) were placed inside the 
bucket-handle lesion of the meniscus samples and sutured 
with 6-0 Vicryl suture (see Fig. 15 for group design). 
Other control groups were prepared by simply suturing the 
meniscal lesion (group 3) or leaving the lesion untreated 
(group 4). All constructs were wrapped into a fibrin glue 
clot, and eight meniscal samples/group were implanted 
into subcutaneous pouches in the backs of nude mice. 
The specimens were harvested at 14 weeks, examined 
grossly, and tested for repairing. Samples were then fixed 
and processed for histological analysis. Results from this 
study showed complete bonding of lesion margins grossly 
in seven out of eight experimental samples (87.5%). 
Conversely, no control samples were repaired (0%), and 
the fracture was still visible by gentle distraction of the 
sample (Fig. 16). Histological analysis showed complete 
adherence between the margins of meniscal fracture and 
the cell-seeded scaffold in experimental group 1 (Fig. 
17A), whereas no repairs were achieved in control group 
specimens (Fig. 17B). Moreover, viable chondrocytes 
were visible at the interface of the pre-seeded slices and 
the meniscal lesion in group 1 specimens. The distinction 
of the exact boundary between the scaffold slice and the 
fracture line of the meniscus was recognizable only by 
the orientation of the fibers of the two tissues, confirming 
good integration of the newly formed tissue with the 
native tissue of the meniscal samples. Conversely, no live 
chondrocytes were present in all control samples—those 
with unseeded meniscal slices in the bucket-handle lesion 
(group 2) and those without slices (groups 3 and 4). In 
our opinion, this work represented a model in which 
the reparative capacity of isolated chondrocytes can be 
evaluated for meniscus fracture. In this nude mouse 
model, the tissue engineered cell-scaffold composite was 
able to achieve repair of a bucket-handle lesion in the 
avascular inner zone of the knee meniscus, a region thus 
far considered to have practically no healing potential. 
Based on the results of this study, we hypothesize 
that a cell-based tissue engineered construct could be 
employed for treating lesions of the knee meniscus 
orthotopically in a large animal model (38). Considering 
that the pig knee adequately resembles the human knee 
in terms of dimensions and load supported, we chose 
the swine model for our investigation. Additionally, a 
previous study demonstrated meniscal tears in pigs do not 
repair spontaneously (39). The purpose of the following 
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work was to assess the capacity of articular chondrocytes 
that are seeded onto a cartilaginous scaffold to repair a 
longitudinal tear of the knee meniscus in swine.
The first part of the study was designed to analyze 
the vascularization of the Yorkshire pig meniscus. 
Four Yorkshire pigs were utilized for these anatomical 
studies. Under general anesthesia, the femoral artery was 
cannulated and perfused with Indian ink, while the flow 
from a catheter inserted in the femoral vein was aspirated. 
The vessels were clamped and the animals were sacrificed. 
The hind limb was disarticulated, fixed in 10% buffered 
formalin for three days. After the limbs were removed 
from fixative, the knee was opened and the menisci were 
harvested for gross analysis. The menisci were cleared 
by immersion in methyl salicylate and further analysis of 
their vascular supply was performed on a diaphanoscope. 
The analysis of our samples demonstrated that vascularity 
of the pig menisci originates from the periphery of the 
structure and does not involve the inner aspect (Fig. 
18). No vascular supply was found in the inner third of 
the meniscus consistent with the vascular supply to the 
meniscus in humans (35). This finding gave us guidance 
as to where the experimental lesion should be made in our 
model for healing in the avascular region.
The second part of the study was designed to analyze 
the potential of cell-based therapy to repair a bucket handle 
lesion in the avascular part of the knee meniscus. From the 
longitudinal aspect of a cross section of devitalized pig 
menisci, meniscal slices (10mm X 2mm X 0.5mm) were 
sectioned (Fig. 19). Sixteen Yorkshire pigs were utilized 
for this study. Cartilage specimens were surgically 
harvested from the patellar groove of the left knee of the 
pigs belonging to the experimental group. As shown in 
the experimental diagram (Fig. 20), chondrocytes were 
isolated by enzymatic digestion and seeded by suspension 
culture onto the previously processed allogeneic meniscal 
slices. Following in vitro culture, a second surgery was 
performed using an anteromedial approach to expose 
the left medial meniscus of the same pig from which 
chondrocytes were harvested. A one-centimeter bucket-
handle lesion was made at the margin of the inner third 
and the outer two thirds of the meniscus. The cell-seeded 
meniscal construct was secured in the lesion in four pigs 
of the experimental group (group 1). Identical lesions 
were made in the left medial meniscus of all other pigs. 
In four animals the lesion was treated with an unseeded 
scaffold (group 2); in four the lesion was sutured without 
insertion of any other material (group 3); in four the lesion 
was left untreated (group 4). The experimental design 
is shown in Fig. 21. Animals were sacrificed after nine 
weeks and the menisci harvested. The specimens were 
examined grossly, fixed in buffered formalin, processed, 
sectioned, and stained with hematoxylin and eosin and 
safranin-O for histological analysis. All histological 
slides were photographed at the lesion sites with a low 
magnification lens (25X) for histomorphometric analysis 
of the percentage of repair obtained in each study group.
Macroscopic evaluation indicated better repair for 
samples of group 1 where three out of four samples from 
this group revealed gross healing of the lesion (Fig. 22A). 
Only one sample from group 2 had approximation of 
the lesion margins, whereas the remaining menisci from 
group 2 (Fig. 22B) did not appear to be repaired grossly. 
No evidence of repair was also observed in all menisci 
from groups 3 (Fig. 22C) and 4 (Fig. 22D). The implanted 
meniscal scaffold itself was macroscopically noted in the 
site in three out of four specimens of group 1, whereas it 
was present in only one sample in group 2.
Histological analysis demonstrated persistence of 
the meniscal tear in all samples from all control groups, 
with a notable gap between the two lesion margins (Fig. 
23). In the analysis of the specimens belonging to the 
experimental samples in group 1, it was clear that the 
seeded chondrocytes transplanted inside the lesion by 
the meniscal chip scaffold were able to synthesize fibro-
cartilaginous matrix. In fact, this tissue was present at 
the boundary of the implanted scaffold and the meniscal 
lesion (Fig. 24A). The safranin-O staining demonstrated 
that this new tissue had sulfated proteoglycans (Fig. 24B). 
In one specimen from group 1, the histological cross-
section was taken at the edge of the bucket-handle lesion 
where the inserted scaffold did not reach into this portion 
of the lesion. The cell-loaded carrier was not involved in 
this particular section (Fig. 25A, small image at top right 
corner), and the lesion was entirely filled with reparative 
tissue (Fig. 25A), which appeared to be constituted by 
neo-tissue presenting an interesting interdigitation with 
the native meniscus (Fig. 25B). Finally, the percentage of 
the repaired interface compared with the total extension 
of the lesion margins (% of repair) was calculated 
histomorphometrically as 30.17 ± 17.83 % for the 
specimens in experimental group 1.  No adherence was 
noted in all samples of control groups 2, 3, and 4.
The results from this study demonstrated that a 
meniscal lesion involving the inner (avascular) one-third 
of the pig meniscus could now benefit from the bonding 
capabilities of the transplanted chondrocytes. We believe 
that these results in a large animal model validate this cell-
based therapy as promising approach to repair tears in the 
avascular third of the meniscus, a region considered thus 
far to have no capacity for healing.
DISCUSSION
The healing of cartilaginous tissues in the joint 
is on of the most challenging clinical problems 
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Fig. 1. Diagram of experimental protocol for the construction 
of cartilaginous composites and implantation in nude 
mice. A) Ovine chondrocytes were isolated by enzymatic 
digestion from hip and shoulder lamb joints, adjusted to a 
concentration of 106 cells/ml and combined with three slices 
of cartilage matrix B), which were previously devitalized 
through several freeze-thaw cycles. The matrices and 
chondrocytes were co-cultured for 21 days. C) Similar 
devitalized matrices were kept in culture also for 21 days 
without viable chondrocytes. D) After culturing, three 
devitalized cartilage slices with chondrocytes (experimental) 
or three slices without chondrocytes (control) were removed 
from the media and joined into a composite with fibrin glue. 
The resulting composites were implanted into the dorsal 
subcutaneous tissue of athymic mice using four separate 
implantation sites (a, b, c, d). E) Two experimental and 
two control cartilage composites randomly assigned were 
implanted into either one of the cranial or one of the caudal 
sites. The composites were harvested at 7, 14, 21, 28 and 42 
days after implantation. Permission has been obtained from 
J Orthop Res (26).
Fig. 2. Macroscopic view of the composites 42 days 
following implantation. A) Experimental composite. 
While the original slices of matrix are discernible, the 
composite has united into a solid cartilaginous mass. B) 
Control composite. The three devitalized cartilage pieces 
slid apart immediately after the removal of the thin fibrous 
capsule, which surrounded the samples at the moment of 
harvesting. Permission obtained from J Orthop Res (26).
Fig. 3. Histologic sections (safranin-O, original 
magnification 200X) of samples after in vitro culture and 
before implantation. A) Experimental sample. Few layers 
of live chondrocytes (LC) are present on the surface of 
devitalized matrix (DM). B) Control sample. No live cells 
are present in this section. Some nuclear debris from 
dead cells remains in the devitalized matrix. Permission 
obtained from J Orthop Res (26).
Fig. 4. Histologic sections (safranin-O, original 
magnification 200X) of composites after implantation. A) 
Experimental composite, 7 days following implantation. 
Two devitalized matrices (DM) are seen on either side. 
Viable chondrocytes forming new matrix (NM) are seen 
on their surfaces. The fibrin glue (FG) forms a relatively 
thick layer between the contact surfaces. B) Experimental 
composite, 14 days following implantation. The two 
layers of viable chondrocytes have increased in thickness 
and the fibrin glue layer has decreased. C) Experimental 
composite, 21 days following implantation. The contact 
space between the devitalized matrices has now been 
completely filled with newly formed matrix. The fibrin glue 
has been largely absorbed. D) Experimental composite, 
28 days following implantation. There is now complete 
confluence of the viable chondrocytes forming new 
matrix between the two devitalized matrices. Permission 
obtained from J Orthop Res (26).
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Fig. 5. Histologic sections (safranin-O, original 
magnification 200X) of composites after implantation. A) 
Experimental composite, 42 days following implantation 
(200X). Newly formed cartilaginous tissue (NM) has 
formed, bonding the devitalized cartilage matrices (DM). 
B) Control composite, 42 days following implantation. 
Fibrous tissue (FT) is observed between the devitalized 
matrices. This tissue stained only with the fast green 
counter-stain and not safranin-O. Moreover, as observed 
by gross analysis, it was not able to achieve bonding 
between the native cartilage slices. No viable chondrocytes 
are present. Permission obtained from J Orthop Res (26).
Fig. 6. Histologic sections (safranin-O) of composites 42 
days after implantation. A) A bud of new cartilage matrix 
(NM) is seen penetrating the devitalized matrix (original 
magnification 200X). B) Another bud of new cartilage 
with branches is seen penetrating the devitalized matrix 
(DM) (original magnification 100X). Permission obtained 
from J Orthop Res (26).
Fig. 7. Graph of (3H)thymidine incorporation into the 
composites at 0, 14, 28 and 42 days following implantation. 
The incorporation into the experimental composites 
decreased from 0 to 28 days with an increase at 42 days. 
The incorporation into the control composites was not 
significantly different from baseline at any time point. The 
differences between the experimental and control groups 
were significant (p<0.05) at each observation period. 
C.P.M. = Counts per minute. Permission obtained from J 
Orthop Res (26).
Fig. 8. Representative example of applied tensile 
displacement (A) and measured tensile load (B) from 
an experimental construct seeded with chondrocytes and 
implanted in vivo. A stress-strain curve (C) was generated 
from this data by normalizing displacement data to 
measured sample thickness and load data to sample 
area. From this curve, ultimate tensile strength (σ
UTS
) and 
fracture strain (ε
f
) were determined by inspection or when 
the measured load was observed to be < 0.05 N, dynamic 
tensile modulus (M) was calculated from slope of the 
linear portion of the curve, and fracture energy (E
f
) was 
calculated as the area under the curve. Permission has 
been obtained from Tissue Eng (27).
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Fig. 9. Histologic sections of samples after biomechanical 
testing (safranin-O staining). A) Experimental sample, 
tested 28 days following implantation (original 
magnification 200X). Failure occurred at the interface 
between the newly formed matrix (NM) and the 
devitalized cartilage matrix (DM). B) Experimental 
sample, tested 42 days following implantation (original 
magnification 100X). When chondrocytes penetrated 
devitalized tissue, fracture occurred at the opposing 
interface in 80% of the sections sampled. Permission has 
been obtained from Tissue Eng (27).
Fig. 10. Time course of changes in tensile strength (A), 
fracture strain (B), fracture energy (C) and tensile 
modulus (D) over 6 weeks in vivo for constructs seeded 
with chondrocytes or unseeded controls. All data are 
shown as mean ± SD. Permission was obtained from 
Tissue Eng (27).
Fig. 11. Diagram showing the experimental protocol. (A) 
Hyaline articular cartilage discs were harvested from 
the articular joints of pigs and devitalized by multiple 
freeze-thaw cycles (B). Chondrocytes were enzymatically 
isolated from cartilage from animals of the same species 
by collagenase digestion (C). Devitalized cartilage 
discs were incubated in the presence of chondrocytes 
in suspension culture for 21 days in order to allow 
chondrocytes to adhere to matrix (D). After in vitro 
culture, pairs of cartilage discs were held in apposition 
in fibrin glue (E) and implanted subcutaneously in nude 
mice for up to eight months. Permission obtained from  J 
Biomed Mater Res (28).
Fig. 12. Time course of changes in tensile strength (A), 
failure strain (B), failure energy (C) and tensile modulus 
(D) over eight months in vivo for constructs seeded with 
chondrocytes or unseeded controls. All data are shown as 
mean ± SD, with the n=5 for experimental and control 
samples. In each figure * denotes the appropriate p value 
for significance of difference between the experimental 
group and the control at that time point, as determined by 
two-factor ANOVA and post-hoc Tukey test. Permission 
obtained from J Biomed Mater Res (28).
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Fig. 13. A) Transmission electron microscopy of a 
chondrocyte far from the interface and surrounded by 
newly synthesized matrix (NM). B) Transmission electron 
microscopy of a chondrocyte at the interface between 
newly synthesized matrix (NM) and the devitalized matrix 
(DM) used as a scaffold. Chondrocytes bordering the DM 
had ruffled borders (arrows) characteristic of remodeling 
activity. Original magnification: A) 31900X; B) 31400X. 
Permission obtained from Tissue Eng (29).
Fig. 14. Experimental protocol for making the scaffolds, 
the meniscal constructs and for their transplantation to 
nude mice. (A) Entire menisci were harvested from lamb 
knees and devitalized by repetitive freezing and thawing 
(B), three sections of the inner part were obtained with a 
scalpel (C) and a four-millimeter bucket-handle incision 
was made within the avascular zone (D). From other 
menisci, chips were cut from the inner third. Articular 
cartilage was harvested from knees and shoulders of 
unrelated lambs (E) and enzymatically digested to 
suspend the chondrocytes (F). The isolated cells were 
co-cultured with the previously made meniscal chips (G). 
Such chips with seeded chondrocytes were sutured inside 
the bucket-handle incision. The samples were wrapped in 
fibrin glue (H) and transplanted to dorsal pouches in nude 
mice at four different sites (I). Permission obtained from 
J Orthop Res (37).
Fig. 15. Study group design. Four different groups 
were established. One specimen from each group was 
transplanted to one of four dorsal pouches on a single 
nude mouse. Eight nude mice were used for a total of eight 
samples per each study group. In experimental group 1, 
a meniscal chip with seeded chondrocytes was sutured 
inside the bucket-handle incision of the devitalized 
meniscal block. In control group 2, a meniscal chip 
without chondrocytes was sutured inside the incision. In 
control group 3, the meniscal incision was simply sutured, 
whereas in control group 4, the meniscal incision was left 
untreated. Permission obtained from J Orthop Res (37).
Fig. 16. Macroscopic analysis of samples upon retrieval 
from nude mice. The experimental sample of group 1 (A) 
shows good repair, with the pre-seeded chip in the middle 
of the bucket-handle lesion, now bridging the edges of the 
meniscal incision (arrow). No separation of the fracture 
edges is evident with traction by the two forceps. On the 
other hand, none of the control samples revealed any 
attempt at repair of the meniscal incision (B). In a sample 
of group 2, the non pre-seeded chip is still visible (arrow) 
not attached to either side of the meniscal incision after 
gentle traction (C). In a sample of group 3, treated only 
with suture (D), and in a sample of group 4, where the 
lesion was left untreated, the meniscal incision alone is 
evident without any attempt at repair. Permission obtained 
from J Orthop Res (37).
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Fig. 17. Photomicrographs of specimens from experimental 
group 1 and from control group 4 (toluidine blue, original 
magnification 20X). A), In experimental samples the 
meniscal chip is located in the middle of the bucket-
handle lesion (arrow) allowing bonding of the two edges 
of the incision through the newly formed tissue, that was 
synthesized by the viable chondrocytes. B) Analysis of 
the control sample showed no repair of the incision, as 
shown in this histological slide of a group 4 specimen. 
Permission obtained from J Orthop Res (37).
Fig. 18. India ink perfusion study; all samples were 
perfused with India ink. A) A medial meniscus after being 
fixed in formalin, and before being harvested from the 
native site; B)  a meniscus, explanted and cleared with 
methyl salicylate, which demonstrated an involvement 
of the vascularity of the outer third of the structure; C)  
another meniscus observed from its inferior surface; D) 
two menisci, belonging to the same knee, analyzed under 
the diaphanoscope. The arrows indicate the anterior horn 
of the menisci. Permission obtained from Am J Sports 
Med (38).
Fig. 19. Experimental protocol for the preparation of the 
allogeneic meniscal scaffold. A) Menisci were harvested 
from knees of pigs and B) devitalized by freeze-thaw 
cycles. C) The inner portion of each meniscus was 
removed and from the inner portion of the longitudinal 
aspect of the outer meniscal sections, D) slices were cut 
and standardized as flat chips measuring approximately 
4 millimeters in width, 10 millimeters in length, and 0.5 
millimeters in thickness. Such an implant was ready to be 
seeded with isolated chondrocytes to form the reparative 
implant. Permission obtained from Am J Sports Med 
(38).
Fig. 20. Experimental design. A) Articular cartilage 
slices were surgically harvested in sterile condition 
and B) chondrocytes were enzymatically isolated. C-
D) Chondrocytes were cultured in the presence of the 
allogeneic meniscal slices in order to be seeded onto 
their surface. E) The obtained seeded meniscal chips 
were surgically implanted in a meniscal bucket-handle 
lesion performed in the same pig, from which the articular 
chondrocytes were isolated. Permission obtained from Am 
J Sports Med (38).
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Fig. 21. Study group design. Sixteen pigs were divided in 
four groups of four animals each. In experimental group 
1, the bucket-handle meniscal lesion was treated by the 
implantation of the allogeneic meniscal slice, seeded with 
autologous chondrocytes. In control group 2, the lesion 
was treated with the implantation of an unseeded meniscus 
slide. In control group 3, the meniscal lesion was simply 
sutured, whereas in control group 4, the meniscal lesion 
was left untreated. Permission was obtained from Am J 
Sports Med (38).
Fig. 22. Macroscopic analysis of samples upon harvesting 
from the animals. (A The experimental meniscus sample 
of group 1 appears to present good gross healing between 
the implanted meniscal scaffold and the bucket-handle 
lesion margins. (B) On the other hand, no signs of repair 
are present in the samples from group 2, C) from group 3, 
and D) from group 4. The arrows show where the original 
lesion was created. Permission was obtained from  Am J 
Sports Med (38).
Fig. 23. Histological analysis (hematoxylin and eosin, 
transverse section through the longitudinal tear) of specimens 
belonging to control groups 2, 3, and 4. In all images the 
lesion is still present. A) Specimen belonging to group 
2 (original magnification 25X), where the meniscus was 
treated with an unseeded meniscal scaffold, which was not 
found at the time of explant; B) specimen belonging to group 
3 (original magnification 100X), treated only with suture; C) 
specimen belonging to group 4 (original magnification 25X), 
where lesion was left untreated. At higher magnification (D) 
taken from specimen in image B, original magnification 
400X, an analysis of the lesion margins demonstrated an 
increased cellularity with fibroblast-like cells (arrows). IN: 
inner part of the meniscus. OUT: outer part of the meniscus. 
Permission was obtained from Am J Sports Med (38).
Fig. 24. Histological analysis (A) hematoxylin and eosin; 
B) safranin-O, original magnification 100X of a group 
1 specimen, treated with the seeded meniscal scaffold 
(transverse section through the longitudinal tear). A) the 
boundary between the native meniscus (right) and the 
seeded scaffold (left) is visible (arrows). B) The safranin-O 
staining shows new matrix production, with highly intensive 
stain at the boundary (arrows) between the seeded scaffold 
(right) and the native meniscus (left). SC: meniscal scaffold. 
NM: native meniscus. Permission was obtained from Am J 
Sports Med (38).
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confronting orthopedic surgeons and basic science 
researchers. Articular cartilage and the inner zone 
of the meniscus do not spontaneously regenerate 
and heal when injured (1,36). When a reparative 
process occurs, it does not resemble the morphology, 
the composition and, most importantly, the 
biomechanical properties of the native tissue. For 
these reasons, investigators have started to pursue 
different pathways to tackle cartilage regeneration 
and healing. In our opinion, cell-based therapy is 
a promising approach to achieve these goals. Cells 
can be modulated in order to duplicate the original 
phenotype of the injured biological structure and 
also can produce an extracellular matrix with the 
capacity to bond and eventually heal the native 
tissue. It is these aspects of cell therapy and their 
ability to bond and heal cartilage that have been the 
subject of our studies. 
Previous studies from other researchers have 
analyzed the integration of entire cartilage blocks 
when put in apposition in vitro (40). In their work 
the main objective was to determine the relationship 
between the integration of the cartilage blocks and 
the deposition of newly synthesized collagen by the 
cells native to the tissue. The same research group 
also analyzed the adhesive capacity of isolated 
chondrocytes seeded onto cartilage matrices in 
vitro (41). The main goal of this other study was 
to determine the effect of the duration of in vitro 
seeding time on the ability of chondrocytes to 
resist detachment from cartilage when subjected to 
mechanical perturbation.
The experiments performed from our group, 
on the other hand, looked into the integration of 
the engineered cartilage, synthesized in vivo by 
chondrocytes seeded onto cartilaginous matrices. 
We have deeply analyzed the phenomena occurring 
at the interface between the newly formed tissue and 
the native cartilage, demonstrating for the fist time 
the presence of interdigitations penetrating from the 
engineered cartilage into the native cartilage. We 
have shown how this phenomenon reinforces the 
biomechanical adhesion between these two tissues.
After having demonstrated and quantified 
the bonding properties of engineered cartilage 
produced by the seeded chondrocytes, we have 
applied this model to repairing of meniscal lesions 
in the heterotopic subcutaneous environment of 
athymic mice. Finally, we have proven the potential 
for this method to repair orthotopically placed 
meniscal lesions in a swine model. We believe 
the results achieved in these experimental series 
represent a logical sequence from fundamental 
understanding of chondrocyte interactions with 
scaffolds to a relevant pre-clinical model. We now 
believe the cartilaginous lesions, and meniscal tears 
in particular, can be successfully repaired with a 
cell-based therapy. Further studies are now under 
investigation, analyzing different cell sources and 
scaffold materials to translate this pre-clinical model 
into clinical application.
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